메뉴 건너뛰기




Volumn 54, Issue 3, 2016, Pages 506-507

Myasthenia gravis exacerbation associated with pembrolizumab

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR; IMMUNOGLOBULIN; PEMBROLIZUMAB; PREDNISONE; PYRIDOSTIGMINE;

EID: 84982171125     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.25055     Document Type: Article
Times cited : (49)

References (7)
  • 1
    • 84893489025 scopus 로고    scopus 로고
    • PD-1 as a potential target in cancer therapy
    • NcDermott DF, Atkins MB. PD-1 as a potential target in cancer therapy. Cancer Med 2013;2:662–673.
    • (2013) Cancer Med , vol.2 , pp. 662-673
    • NcDermott, D.F.1    Atkins, M.B.2
  • 2
    • 84917708727 scopus 로고    scopus 로고
    • Arthritis and tenosynovitis associated with the anti-PD1 antibody pembrolizumab in metastatic melanoma
    • Chan MM, Kefford RF, Carlino M, Clements A, Manolios N. Arthritis and tenosynovitis associated with the anti-PD1 antibody pembrolizumab in metastatic melanoma. J Immunother 2015;38:37–39.
    • (2015) J Immunother , vol.38 , pp. 37-39
    • Chan, M.M.1    Kefford, R.F.2    Carlino, M.3    Clements, A.4    Manolios, N.5
  • 3
    • 84937520489 scopus 로고    scopus 로고
    • Myasthenia gravis associated with ipilimumab and nivolumab in the treatment of small cell lung cancer
    • Loochtan AI, Nickolich MS, Hobson-Webb LD. Myasthenia gravis associated with ipilimumab and nivolumab in the treatment of small cell lung cancer. Muscle Nerve 2015;52:307–308.
    • (2015) Muscle Nerve , vol.52 , pp. 307-308
    • Loochtan, A.I.1    Nickolich, M.S.2    Hobson-Webb, L.D.3
  • 4
    • 84954530274 scopus 로고    scopus 로고
    • Acetylcholine receptor binding antibody-associated myasthenia gravis and rhabdomyolysis induced by nivolumab in a patient with melanoma
    • Shirai T, Sano T, Kamijo F, Saito N, Miyake T, Kodaira M, et al. Acetylcholine receptor binding antibody-associated myasthenia gravis and rhabdomyolysis induced by nivolumab in a patient with melanoma. Jpn J Clin Oncol 2016;46:86–88.
    • (2016) Jpn J Clin Oncol , vol.46 , pp. 86-88
    • Shirai, T.1    Sano, T.2    Kamijo, F.3    Saito, N.4    Miyake, T.5    Kodaira, M.6
  • 5
    • 84919814988 scopus 로고    scopus 로고
    • Myasthenia gravis induced by ipilimumab in patients with metastatic melanoma
    • See comment in PubMed Commons below
    • Johnson DB, Saranga-Perry V, Lavin PJ, Burnette WB, Clark SW, Uskavitch DR, et al. Myasthenia gravis induced by ipilimumab in patients with metastatic melanoma. See comment in PubMed Commons below J Clin Oncol 2014;32:1–3.
    • (2014) J Clin Oncol , vol.32 , pp. 1-3
    • Johnson, D.B.1    Saranga-Perry, V.2    Lavin, P.J.3    Burnette, W.B.4    Clark, S.W.5    Uskavitch, D.R.6
  • 6
    • 84896934432 scopus 로고    scopus 로고
    • Atypical neurological complications of ipilimumab therapy in patients with metastatic melanoma
    • Liao B, Shroff S, Kamiya-Matsuoka C, Tummala S Atypical neurological complications of ipilimumab therapy in patients with metastatic melanoma. Neuro Oncol 2014;16:589–593.
    • (2014) Neuro Oncol , vol.16 , pp. 589-593
    • Liao, B.1    Shroff, S.2    Kamiya-Matsuoka, C.3    Tummala, S.4
  • 7
    • 34548137330 scopus 로고    scopus 로고
    • Anti-musk antibody after thymectomy in a previously seropositive myasthenic child
    • Saulat B, Maertens P, Hamilton WJ, Bassam BA. Anti-musk antibody after thymectomy in a previously seropositive myasthenic child. Neurology 2007;69:803–804.
    • (2007) Neurology , vol.69 , pp. 803-804
    • Saulat, B.1    Maertens, P.2    Hamilton, W.J.3    Bassam, B.A.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.